Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| foot and ankle center, Iowa | UNKNOWN |
Not provided
Not provided
Not provided
This study is looking to test a non-compressive semiconductor embedded ankle sleeve and sock for post hallux valgus correction surgery rehabilitation. Hallux valgus (HV), commonly known as a bunion, is one of the most prevalent forefoot deformities. It affects approximately 23% of adults aged 18 to 65 and 36% of those over 65. Given the high incidence of HV, various surgical correction methods have been developed, with first tarsometatarsal (TMT) arthrodesis (Lapiplasty Arthrodesis) and first metatarsophalangeal (MTP) arthrodesis demonstrating the highest success rates in restoring function and preventing recurrence. Post-surgical symptoms typically include pain, swelling, and tenderness, but with proper rehabilitation and preventive measures, patients generally return to activity within weeks to months.The semiconductor embedded fabric increases blood circulation through activation of the embedded elements with body heat while worn and releases far infrared waves as well as negative ions. This energy has an effect inside the body that increases oxygen and nutrient flow to tissues, and can help to decrease pain and inflammation. This study is testing this technology to see if it can be used as a non-pharmacological treatment for rehabilitation post hallux valgus correction surgery.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Active Device | Active Comparator | Semiconductor Embedded Ankle Sleeve and Sock |
|
| Placebo Device | Placebo Comparator | Identical device absent of semiconductors |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Semiconductor embedded ankle sleeve and sock | Device | The active device contains semiconductors embedded in the ankle sleeve and sock |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in participant Foot and Ankle Outcome Score (FAOS) | Changes in participant function and pain as determined by the Foot and Ankle Outcome score (FAOS) FAOS: Lowest score: 0 (extreme symptoms/limiations) Highest score: 100 (no symptoms or limitations) | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change in participant Foot Function Index (FFI) | Changes in participant foot function and pain as determined by the Foot Function Index (FFI) as compared to the placebo group, FFI: Lowest score: 0 (no pain or disability) Highest Score: 100 (extreme pain and disability) | 3 months |
| Changes in participant American Orthopedic Foot and Ankle Society-Hallux Valgus Score (AOFAS) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Foot and Ankle Center of Iowa | Ankeny | Iowa | 50023 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo ankle sleeve and sock | Device | Identical ankle sleeve and sock absent of semiconductors |
|
Changes in participant hallux valgus function and pain as determined by the American Orthopedic Foot and Ankle Society-Hallux Valgus Score (AOFAS) compared to placebo group. AOFAS-Hallux MTP-IP Score: Lowest Score: 0 ( severe pain and disability) Highest Score: 100 ( no pain or disability) |
| 3 months |
| Participant-reported changes in pain | Reduction in post hallux vagus correction surgery pain as determined by the Visual Analog Scale (VAS) compared to placebo group. Visual Analog Scale for Pain (VAS): Minimum Value: 0 (no pain) Maximum Value: 10 (worst possible pain) | 3 months |
| Changes in oral medication intake compared to placebo group | As measured by collecting concomitant medication information at baseline and changes throughout participation in the study. | 3 months |
| Changes in swelling of the foot compared to placebo group | Changes in swelling of the anterior foot width, anterior foot circumference, hallux valgus width, hallux valgus circumference, and 4 cm above and below the patella circumference measurements will be taken in cm. | 3 months |
| Changes in participant soft tissue thickness compared to placebo group | Changes in participant soft tissue thickness as determined by radiographic assessments (x-ray) of the width of the hallux values in cm. | 3 months |